Advancis Pharmaceutical Corp.
This article was originally published in Start Up
Executive Summary
Advancis Pharmaceutical Corp. is tackling antibiotic resistance with pulsed dosing technology that delivers repetitive bursts of anti-infective medications--both existing drugs and NCEs--in an attack pattern that denies microorganisms the chance to regroup between doses. This approach promises to work with lower total dosages and shorter durations of therapy, reducing side effects and aiding patient compliance.